BROWN MICHAEL S 1174475 Data last updated 2024-05-11 06:58:14 -0500 US CDT
Latest Holdings
Notice: Data summarized from Form 3,4,5 filings, which do not include holdings/transactions of investment institution(s), if any, managed by the reporter.
Non-derivative Transactions CSV download
Tips: type "code_s" to show transactions with code "S".
| Filing Date | Transaction Date | Operation Date | Original Filing | Reporter | Relation | Opr | Amounta | %(Owned)b | ‱(SO)c | Avg Prcd | Account | Type | Full Name | Code | Remain | Shares Outstanding (Million)e |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2023-12-29 | 2023-12-27 | 2023-12-27 | 4 | Brown Michael S | DIRECTOR | dsp | 2049.0 | 62.17 | 0.19 | 898.0 | Direct | Common Stock | REGENERON PHARMACEUTICALS, INC. | code S | 1247.0 | 107.13 (REGN) |
| 2023-12-29 | 2023-12-27 | 2023-12-27 | 4 | Brown Michael S | DIRECTOR | acq | 2049.0 | 62.17 | 0.19 | 482.68 | Direct | Common Stock | REGENERON PHARMACEUTICALS, INC. | code M | 3296.0 | 107.13 (REGN) |
| 2023-12-29 | 2023-12-27 | 4 | Brown Michael S | DIRECTOR | holding | 6162.0 | 0 | 0.58 | 0.0 | By Trust | Common Stock | REGENERON PHARMACEUTICALS, INC. | NA | 107.13 (REGN) | ||
| 2023-12-29 | 2023-12-27 | 4 | Brown Michael S | DIRECTOR | holding | 5000.0 | 0 | 0.47 | 0.0 | By Slat | Common Stock | REGENERON PHARMACEUTICALS, INC. | NA | 107.13 (REGN) | ||
| 2024-01-04 | 2024-01-02 | 4 | Brown Michael S | DIRECTOR | holding | 6162.0 | 0 | 0.58 | 0.0 | By Trust | Common Stock | REGENERON PHARMACEUTICALS, INC. | NA | 107.13 (REGN) | ||
| 2024-01-04 | 2024-01-02 | 4 | Brown Michael S | DIRECTOR | holding | 5000.0 | 0 | 0.47 | 0.0 | By Slat | Common Stock | REGENERON PHARMACEUTICALS, INC. | NA | 107.13 (REGN) | ||
| 2024-01-04 | 2024-01-02 | 2024-01-02 | 4 | Brown Michael S | DIRECTOR | acq | 135.0 | 9.77 | 0.01 | 0.0 | Direct | Common Stock | REGENERON PHARMACEUTICALS, INC. | code A | 1382.0 | 107.13 (REGN) |
Derivative Transactions
Tips: type "code_m" to show transactions with code "M".
| Filing Date | Transaction Date | Operation Date | Original Filing | Reporter | Relation | Opr | Amounta | %(Owned)b | ‱(SO)c | Avg Prcd | Account | Type | Full Name | Code | Remain | Shares Outstanding (Million)e |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2023-12-29 | 2023-12-27 | 2023-12-27 | 4 | Brown Michael S | DIRECTOR | dsp | 2049.0 | 100.0 | 0.19 | 482.68 | Direct | Non Qualified Stock Option (Right To Buy) | REGENERON PHARMACEUTICALS, INC. | code M | 0.0 | 107.13 (REGN) |
| 2024-01-04 | 2024-01-02 | 2024-01-02 | 4 | Brown Michael S | DIRECTOR | acq | 1607.0 | 100.0 | 0.15 | 888.34 | Direct | Non Qualified Stock Option (Right To Buy) | REGENERON PHARMACEUTICALS, INC. | code A | 1607.0 | 107.13 (REGN) |
a Sum of same type of securities in the form
b Relative to reporter's shares owned before (disposition) or after (acquisition) operation
c Relative to issuer's shares outstanding (1/10000)
d Average price for securities of the same type. Check the original form for detailed prices of multiple transactions
e Documented shares outstanding closest to the transaction date
Note: Corporate may change mapped CIK when merge or spin-off happen. Please report error if the ticker you searched for does not have up-to-date insider trading information.
Show up to records per table for current tier. Access Guide)